Skip to main content
Premium Trial:

Request an Annual Quote

CLARIFICATION: University of Washington Will Use Amersham Proteomics, Microarray Systems

This brief mistakenly reported that Amersham's 2-D gel system lets researchers compare as many as three proteins at a time. In fact, the system allows for simultaneous comparisons of up to three protein samples.

NEW YORK, March 11 - University of Washington researchers will use Amersham proteomics and mRNA expression systems in order to explore cell function, the two said today.

 

Amersham will provide the UW researchers with its 2-D Differential In-Gel Electrophoresis system and DNA microarray platform. Its 2-D gel system allows for simultaneous comparisons of up to three protein samples at a time.

 

The system will be located in the lab of Roger Bumgarner, director of UW's Center for Expression Arrays.

 

Bumgarner, who is a research scientist in the university's department of molecular biotechnology, is now working on a high throughput genotyping system that makes use of simple sequence repeat polymorphisms. He is also developing software to be used  for the analysis of differential hybridizations on high density DNA arrays.

 

Financial details of the Amersham deal were not disclosed.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.